A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

South Korea

National Cancer Center, Goyang

Seoul National University Bundang Hospital, Seongnam

Samsung Medical Center, Seoul

Severance Hospital, Seoul